Immunologic Research

, 5:33 | Cite as

Human natural cytotoxic cells: Distinctive membrane markers and patterns of reactivity

  • Jana Stankova
  • Marek Rola-Pleszczynski
Cellular Immunology, Symposium


Natural Killer Cell Natural Killer Activity Large Granular Lymphocyte K562 Cell Line Human Natural Killer Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Timonen, T.; Ranki, A.; Saksela, E.; Hayry, P.: Human natural cell-mediated cytotoxicity against fetal fibroblasts. Cell. Immunol.48: 121–132 (1979).PubMedCrossRefGoogle Scholar
  2. 2.
    Herberman, R.B.; Timonen, T.; Reynolds, C.; Ortaldo, J.R.: in Herberman, Natural cell-mediated ummunity against tumors, p. 89 (Academic Press, New York 1980).Google Scholar
  3. 3.
    Fitzgerald, P.A.; Evans, R.; Kirkpatrick, D.; Lopez, C.: Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets. J. Immun.130: 1663–1667 (1983).PubMedGoogle Scholar
  4. 4.
    Herberman, R.B.; Djeu, J.Y.; Ortaldo, J.R.; Riccardi, C.; Bonnard, G.D.; Holden, H.T.; Fagnari, R.; Santoni, A.; Pucetti, P.: Natural killer cells. Characteristics and regulation of activity. Immunol. Rev.44: 43–70 (1979).PubMedCrossRefGoogle Scholar
  5. 5.
    Herbernan, R.B.; Holden, H.T.: Natural cell-mediated immunity. Adv. Cancer Res.27: 305–377 (1978).CrossRefGoogle Scholar
  6. 6.
    Kiessling, R.; Haller, O.: Natural killer cells in the mouse: an alternative immune surveillance mechanism? Contemp. Top. Immunobiol.8: 171–201 (1978).PubMedGoogle Scholar
  7. 7.
    Zarling, J.M.; Clouse, K.A.; Biddison, W.E.; Kung, P.C.: Phenotypes of human natural killer cell populations detected with monoclonal antibodies. J. Immun.127: 2775–2580 (1981).Google Scholar
  8. 8.
    Minato, N.; Reid, L.; Bloom, B.R.: On the heterogeneity of murine natural killer cells. J. exp. Med.154: 750–762 (1981).PubMedCrossRefGoogle Scholar
  9. 9.
    Kumar, V.; Luevano, E.; Benett, M.: Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow dependent natural killer cells. J. exp. Med.150: 531–547 (1979).PubMedCrossRefGoogle Scholar
  10. 10.
    Kimber, I.; Moore, M.: Naturally cytotoxic tonsillar lymphocytes: a manifestation of heterogeneity among human NK cells. Scand. J. Immunol.17: 29–36 (1983).PubMedCrossRefGoogle Scholar
  11. 11.
    Bol, S.; Ronteltap, C.; Van Der Griend, R.; Bolhuis, R.: NK activity is also exerted by non-LGL lacking the NK marker HNK-1. Immunbiology163: 401 (1982).Google Scholar
  12. 12.
    Bloom, E.T.; Korn, E.L.: Quantification of natural cytotoxicity by human lymphocyte subpopulations isolated by density: heterogeneity of the effector cells. J. immunol. Methods58: 323–335 (1983).PubMedCrossRefGoogle Scholar
  13. 13.
    Abo, T.; Balch, M.: Characterization of HNK-1+ (Leu-7) human lymphocytes. III. Interferon effects on spontaneous cytotoxicity and phenotypic expression of lymphocyte subpopulations delineated by the monoclonal HNK-1 antibody. Cell. Immunol.73; 376–384 (1982).PubMedCrossRefGoogle Scholar
  14. 14.
    Lanier, L.L.; Le, A.M.; Phillips, J.H.; Warner, N.L.; Babcock, G.F.: Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immun.131: 1789–1796 (1983).PubMedGoogle Scholar
  15. 15.
    Marolda, R.; Tilden, A.B.; Abo, T.; Dougherty, P.A.; Balch, C.M.: Characterization of subset of human natural killer cells that express OKMI but lack HNK-1 (Leu-7) antigens. Scand. J. Immunol.20: 261–265 (1984).PubMedCrossRefGoogle Scholar
  16. 16.
    Ortaldo, J.R.; Sharrow, S.O.; Timonen, T.; Herberman, R.B.: Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J. Immun.127: 2401–2409 (1981).PubMedGoogle Scholar
  17. 17.
    Hercend, T.; Reinherz, E.L.; Meuer, S.; Schlossman, S.F.; Ritz, J.: Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature. Lond.301: 158–160 (1983).PubMedCrossRefGoogle Scholar
  18. 18.
    Benczur, M.; Sarmay, G.; Laskay, T.; Gyodi, E.; Petranyi, G.G.; Gergely, J.; Recognition of autologous and allogeneic lymphocytes and tumor cells by human natural killer cells. Mol. Immunol.19: 1331–1340 (1982).PubMedCrossRefGoogle Scholar
  19. 19.
    Yasukawa M; Zarling, J.M.: Autologous herpes simplex virus-infected cells are lysed by human natural killer cells. J. Immun.131: 2011–2016 (1983).PubMedGoogle Scholar
  20. 20.
    Warner, N.L.; Tai, A.S.: Analysis of the differentiation lineage of NK cells. Fed. Proc.40: 2711–2716 (1981).PubMedGoogle Scholar
  21. 21.
    Stutman, O.; Paige, C.J.; Feofigarella, E.: Natural cytotoxic cells against solid tumors in mice. 1. Strain and age distribution and target cell susceptibility. J. Immun.121: 1819–1826 (1978).PubMedGoogle Scholar
  22. 22.
    Lattime, E.C.; Pecoraro, G.; Stutman, O.: Natural cytotoxic cells against solid tumors in mice. IV. Natural cytotoxic (NC) cells are not activated natural killer (NK) cells. Int. J. Cancer30: 471–477 (1982).PubMedCrossRefGoogle Scholar
  23. 23.
    Rola-Plesczynski, M.; Lieu, H.: Human natural cytotoxic lymphocytes: definition by a monoclonal antibody of a subset which kills an anchoragedependent target cell line but not the K-562 cell line. Cell. Immunol.82: 326–333 (1983).CrossRefGoogle Scholar
  24. 24.
    Rola-Pleszczynski, M.; Lieu, H.; Sullivan, A.K.; Girard, M.: Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells. J. clin. Invest.76: 1927–1931 (1985).PubMedCrossRefGoogle Scholar
  25. 25.
    Rola-Pleszczynski, M.; Gagnon, L.; Sirois, P.: Leukotriene B4 augments human natural cytotoxic cell activity. Biochem. biophys. Res. Commun.113: 531–537 (1983).PubMedCrossRefGoogle Scholar
  26. 26.
    Stankova, J.; Rola-Peszczynski, M.: Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity. J. Immun.135: 3719–3728 (1985).PubMedGoogle Scholar
  27. 27.
    Rola-Pleszczynski, M.; Lieu, H.; Girard, M.: Human natural cytotoxic lymphocytes: activation by measles virus and SSPE virus-infected cells (submitted for publication, 1986).Google Scholar
  28. 28.
    Stankova, J.; Rola-Pleszczynski, M.: Comparative activities of natural cytotoxic and natural killer cell populations in cord blood and adult peripheral blood: enhancement by fucose and interleukin 2. Fed. Proc.45: 385 (1986).Google Scholar

Copyright information

© Humana Press Inc. 1986

Authors and Affiliations

  • Jana Stankova
    • 1
  • Marek Rola-Pleszczynski
    • 1
  1. 1.Immunology Division, Department of Pediatrics, Faculty of MedicineUniversity of SherbrookeSherbrooke(Canada)

Personalised recommendations